Santa Clara, CA – February 14, 2019, ELEVET Technologies of Worthington, OH and HD Medical, Inc. of Silicon Valley, CA today announce they have signed a distribution agreement. According to the terms of the agreement, ELEVET will offer HD StethVet® to the veterinarian community nationwide. HD Steth is an intelligent stethoscope with integrated EKG; this provides instantaneous insights from evidence-based medical diagnosis of an animal’s health.

HD StethVet’s ruggedized packaging has the look and feel of the familiar stethoscope making it a natural transition for veterinarians. HD StethVet transforms the way medicine is practiced at the point-of-care through real-time visualization of cardiac waveforms, EKG and body sounds on a mobile device. With patented sound processing technology which provides optimum amplification and noise cancellation, HD StethVet is perfect for environments with significant ambient sound such as a busy veterinary clinic.

“We are very excited to have ELEVET Technologies offering HD Medical’s latest intelligent stethoscope solution, HD StethVet, to help veterinarians more effectively care for their animal patients,” states Arvind Thiagarajan, HD Medical Founder and CEO. “Additionally, the ability to display, record, save and transfer visual plus audio health data for group consumption makes HD StethVet ideal for veterinary colleges where the next generation of veterinarians are being taught.

“Now veterinarians have access to the only advanced intelligent stethoscope with EKG, enabling accurate and instant diagnosis of animal cardiac and body conditions,” said Chris Scott, ELEVET Technologies President. “This is particularly important in clinics where follow-up tests can be difficult, time consuming and costly.” HD StethVet is consistent with ELEVET’s philosophy of delivering the latest design, technological and usability breakthroughs to better serve veterinarians and their patients, helping to grow veterinary practices.


About ELEVET

ELEVET Technologies is a marketing and distribution company of high-quality medical equipment and supplies to help grow veterinary practices. We have over 20-years of industry experience, supplying products from leading manufacturers around the world. For more information please visit www.ele-vet.com.

About HD Medical, Inc.

HD Medical, Inc. is a Silicon Valley-based innovator of digital health solutions for AI-enabled detection and management of cardio vascular disease (CVD). The company delivers its intelligent cardiac care solutions and products globally to medical professionals, hospitals and medical institutions as well as veterinarians through channel partners. For more information please visit www.hdmedicalgroup.com.

Note to editors: HD StethVet is a registered trademark of HD Medical, Inc. All other company, organization, product or alliance names mentioned herein remain the property of their respective owners.

Click here to view PDF.

It’s February 7thand the medical community is observing Congenital Heart Defect Awareness Week sponsored by the American Heart Association to encourage awareness and education about congenital heart defects (CHDs). This week has been set aside to honor those born with a heart defect and all of the families and friends touched by children with heart defects. As participants of multiple CHD trials and validation studies lets discuss CHD challenges and solutions for rapid CHD detection.

According to the American Heart Association, about one child out of 100 births every year in the US is born with a CHD condition. This is due to a problem that happens as the child’s heart is developing during pregnancy, before the child is born. CHDs are the most common type of birth defects and people live with heart defects throughout their lives. As we all know, there are many types of congenital heart defects and the most common involve the inside walls of the heart, the valves of the heart, or the large blood arteries and veins carrying blood to and from the heart. Some of these heart defects require no treatment; however others require treatment soon after birth. Treatments which have many dependencies can include medications, catheter procedures, surgery, and sometimes heart transplants. Because cardiac diagnosis and treatment has greatly improved, more children are surviving and many CHD adults are living full complete lives. 

Regardless of treatment, detection and monitoring are key for managing CHD; the gold standard has been ultrasound echocardiogram, however recent clinical studies in India have validated that new EKG-enabled intelligent stethoscope technology can serve as a precursor to ultrasound echocardiogram for CHD detection and monitoring.

This new technology solution which integrates digital auscultation with EKG functionality and diagnostic imaging in the familiar shape and size of a stethoscope is called HD Steth.  HD Steth leverages digital health technologies to instantly detect and diagnose CHD. This represents a paradigm shift at the point-of-care setting.  Now medical professionals can instantly identify a patient’s cardiac condition, capture and share patient data, and identify cardiac defects in real-time improving patient quality-of-life.